David Enloe Jr Net Worth & Insider Trades
David Enloe Jr - Chief Executive Officer, Recro Pharma, Inc
What is David Enloe Jr's Net Worth?
The current estimated net worth of Recro Pharma, Inc's Chief Executive Officer, David Enloe Jr, is estimated to be about $0 . David Enloe Jr owns about 524,879 units of Recro Pharma, Inc common stock. In the last 2 years at Recro Pharma, Inc, David Enloe Jr has sold an estimated value of $0 worth.
What is David Enloe Jr's Past Insider Trading?
David Enloe Jr's largest purchase order was 1,725 units , worth over $2.9K on November 16, 2021. In total, David Enloe Jr has made about 7 transactions over 2 years of their time at Recro Pharma, Inc. David Enloe Jr usually trades in January and December, with the busiest year in 2022. The most recent transaction was a purchase order of 512 units , worth over $1K on March 17, 2022.
DAVID ENLOE JR
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Recro Pharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| J. David Enloe, Jr. | 2020 | $10,577 | - | $660,001 | $400,544 | - | $1,678 | $1,072,800 |
| Ryan D. Lake | 2020 | $198,985 | $48,000 | $1,058,040 | $744,327 | $107,640 | $24,673 | $2,181,665 |
| Ryan D. Lake | 2019 | $319,777 | $69,440 | $623,276 | $334,200 | $138,880 | $44,038 | $1,529,611 |
| Gerri Henwood | 2020 | $308,654 | $111,240 | - | - | - | $21,166 | $441,060 |
| Gerri Henwood | 2019 | $553,846 | - | $2,608,537 | $1,062,199 | $360,000 | $38,402 | $4,622,984 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1588972/000156459021015283/reph-def14a_20210420.htm
What are Recro Pharma, Inc's Past Insider Trades?
Recro Pharma, Inc's most recent insider trade came on March 17, 2022 by David Enloe Jr who bought 512 units worth $1K . In the last 8 years, insiders at Recro Pharma, Inc have sold an estimated value of $26.27M and bought an estimated value of $15.87M worth of shares. Insider trading is most common in December, with the busiest year in 2017. The most active traders at the company are Ryan D. Lake, Chief Financial Officer, Geraldine Henwood, Director, and Scp Vitalife Partners Ii Lp .
Recro Pharma, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||